Active Ingredient: TRILACICLIB DIHYDROCHLORIDE
Proprietary Name: COSELA
Dosage Form; Route of Administration: POWDER; INTRAVENOUS
Strength: EQ 300MG BASE/VIAL
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N214200
Product Number: 001
Approval Date: Feb 12, 2021
Applicant Holder Full Name: G1 THERAPEUTICS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
